Linden Thomson: It’s no surprise first vaccines came from biotech rather than large-cap pharma
Axa Framlington Biotech fund manager on vaccine makers thriving even after Covid
Axa Framlington Biotech fund manager on vaccine makers thriving even after Covid
Artemis Global Select and Mid Wynd co-manager says portfolio themes have performed well amid the pandemic
Sanlam fund manager reflects on the £282m Real Assets fund he launched two years ago
Odey Special Situations manager unpacks his unique merger arbitrage and long/short approach a year on from launch
The £550m Baillie Gifford Positive Change fund is one of the top performers in the IA Global sector
Tyndall North American fund manager reckons US equities are less efficient in the age of coronavirus
Financial education is vital to encourage new generation of asset managers
RLAM head of sustainable investments on how refusing to drop sustainability label has paid off
Aspiring sleuth says the options at Matthews Asia for exploring Chinese small caps are limitless
Stuart Rhodes launched the Global Dividend Fund during the financial crisis
Ben Peters of Evenlode on the meteoric rise of the boutique firm out of the ashes of the financial crunch and how his training as a physicist informs the scientific approach to stock selection that has allowed the firm’s flagship fund to hit a cool £2bn.
After more than three decades as a stockbroker, James Baker, manager of Chelverton UK Equity Growth, has spent the past four years in fund management, bringing a wealth of experience to his stockpicking process.